This week in science, the enigmatic Dragon Man is identified, revealing secrets of our evolutionary past. Additionally, researchers inch closer to locating the universe's elusive missing matter, while groundbreaking studies on psilocybin show promise for long-term depression relief.
A new study indicates that a single dose of psilocybin can alleviate depression for up to five years, offering hope for those with major depressive disorder. This groundbreaking research highlights the potential of psychedelics in mental health treatment.
Recent research suggests that psilocybin, the active compound in magic mushrooms, may alleviate depressive episodes in bipolar II disorder, showing promise without triggering mania. The trial found significant improvements among participants, indicating a potential new treatment avenue.
A new phase 2 trial reveals that a single dose of psilocybin, combined with psychological support, significantly reduces depression in over half of cancer patients, lasting up to two years.
Meta is set to unveil its new smart glasses in partnership with Oakley, aimed at athletes and sports enthusiasts. The official announcement is coming this Friday, promising a new era of wearable technology.
A new clinical trial shows that a single dose of psilocybin can significantly reduce depression and anxiety in cancer patients. With promising long-term results, this therapy offers hope for many.
Meta's Ray-Ban smart glasses have sold over 2 million units since their late 2023 release, but will they achieve mass adoption or suffer the same fate as Google Glass? Insights on their future impact and competition.
